News

Distinct patterns of brain inflammation identified through PET imaging may explain disease progression and severity in ...
Pratap Chand, MD, DM, FRCP, University of Louisville School of Medicine, Division of Movement Disorders, Frazier Rehab Neuroscience Institute, 220 Abraham Flexner Way, Ste 1503 Louisville, KY ...
Pratap Chand, MD, DM, FRCP, University of Louisville School of Medicine, Division of Movement Disorders, Frazier Rehab Neuroscience Institute, 220 Abraham Flexner Way, Ste 1503 Louisville, KY ...
A novel PET imaging study has identified unique patterns of neuroinflammation in patients with progressive apraxia of speech ...
A novel PET imaging approach has revealed distinct patterns of brain inflammation in patients with progressive apraxia of ...
A novel PET imaging approach has revealed distinct patterns of brain inflammation in patients with progressive apraxia of ...
GemVax announced on the 29th that its progressive supranuclear palsy (PSP) treatment drug 'GV1001' has been designated as an orphan medicinal product (OMP) by the European Medicines Agency (EMA).
Aim To evaluate a standardised MRI acquisition protocol and a new image rating scale for disease severity in patients with progressive supranuclear palsy (PSP) and multiple systems atrophy (MSA) in a ...
A machine learning model differentiated Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. AUROCs and predictive values for distinguishing Parkinson's from mimics ...
More information: Miriam Scarpa et al, Post mortem validation and mechanistic study of UCB‐J in progressive supranuclear palsy patients' brains, Alzheimer's & Dementia (2024). DOI: 10.1002/alz.14409 ...